PTCT — PTC Therapeutics Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for PTC Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-524	-559	-627	-363	683
Depreciation
Deferred Taxes
Non-Cash Items	232	203	252	135	42.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-23.8	-94.9	26.3	101	-52.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-251	-357	-158	-108	711
Capital Expenditures	-28.2	-32	-28.4	-6.5	-8.86
Purchase of Fixed Assets
Other Investing Cash Flow Items	247	322	-148	50.7	-853
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	219	290	-177	44.2	-862
Financing Cash Flow Items	0	-51.9	918	224	234
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	20.9	168	646	256	331
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-19.1	98.7	314	185	203